Making waves.
Changing outcomes.

With its simple approach to removing harmful inflammation from the body, SeaStar Medical is advancing the science of immunomodulation to prevent the devastation of a cytokine storm

fight the cytokine storm

Transform the cytokine storm

Patented technology that transforms key inflammatory messengers from agents of destruction to agents of repair

improve patient outcomes

Improve patient
outcomes

Enables you to alter patients’ disease progression and put them on the path to healing

keep workflow on track

Keep workflow
on track

Seamlessly integrates into your critical-care workflow so you won’t miss a beat

Giving you the power to defeat a serious clinical threat

Critically ill patients in the throes of a cytokine storm are facing an alarming, urgent situation. That’s because this dangerous, dysregulated hyperinflammatory response can cause multiorgan damage and in severe cases, death.

SeaStar Medical is an innovator with groundbreaking solutions that give you the power to stop this serious threat before it can do irreparable harm to the patients you are fighting for.

Backed by rigorous clinical research and robust scientific evidence, our patented approach is designed to support your clinical end goals including reducing dialysis dependency, improving outcomes, and saving precious lives.

Introducing the game-changing Selective Cytopheretic Device (SCD)

COVID-19, acute respiratory distress syndrome, acute kidney injury, and many other health issues can result in a dangerous cytokine storm. With SeaStar Medical’s novel, simple-to-use SCD immunomodulation technology, you can quickly rescue patients from a cytokine storm, regardless of how it was triggered, and restore reparative functionality to the body and potentially reverse injury.

The SCD is an investigational device and is not currently available for sale. Please check back for further updates on device availability in your region.

Representative product illustration; product subject to future changes.

Better outcomes

A shorter treatment regimen to reach the desired effect may reduce dependency on dialysis and time in the ICU. This can help put patients on the road back to recovery sooner and free up resources more quickly.